The present invention relates to (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane and pharmaceutically acceptable salts thereof, compositions comprising (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or a pharmaceutically acceptable salt thereof, and methods for treating or preventing a disorder alleviated by inhibiting dopamine reuptake. In one embodiment, the disorder is attention-deficit disorder, depression, obesity, Parkinson's disease, a tic disorder, or an addictive disorder. The (-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane or pharmaceutically acceptable salt thereof is preferably substantially free of its corresponding (+)-enantiomer.

 
Web www.patentalert.com

< Aglycon dammarane sapogenins, their use as anti-cancer agents, and a process for producing same

< Single or multi-mode cardiac activity data collection, processing and display obtained in a non-invasive manner

> Microprocessor controlled ambulatory medical apparatus with hand held communication device

> System and method for arrhythmia discrimination

~ 00259